LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

Home・Aktien・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Open

BrancheGesundheitswesen

35.42 0.34

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

35.35

Max

35.86

Schlüsselkennzahlen
By Trading Economics
Einkommen	11M 51M
Verkäufe	39M 239M
KGV Branchendurchschnitt	11.126 79.874
EPS	1.08
Gewinnspanne	21.242
Angestellte	268
EBITDA	14M 73M

Empfehlungen
By TipRanks
Empfehlungen	Starkes Kaufsignal
12-Monats-Prognose	+30.16% upside

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	344M 2B
Vorheriger Eröffnungskurs	35.08
Vorheriger Schlusskurs	35.42

Nachrichtenstimmung

By Acuity

51%

49%

304 / 374 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Weak Bullish Evidence

29.8 / N/A Unterstützung & Widerstand

Harmony Biosciences Holdings Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

26. Nov. 2025, 17:44 UTC

Ergebnisse

Wichtige Markttreiber

Deere Warns of Tough Year Ahead as Earnings, Sales Fall -- Update

27. Nov. 2025, 00:00 UTC

Market Talk

Rio Tinto's Coming Investor Briefing Seen Focused on Costs, Lithium, Asset Sales -- Market Talk

26. Nov. 2025, 23:47 UTC

Market Talk

Nikkei May Rise as Fears About Potential AI Bubble Ease -- Market Talk

26. Nov. 2025, 23:28 UTC

Market Talk

Mortgage Refinancing in New Zealand Will Spur Recovery -- Market Talk

26. Nov. 2025, 23:21 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

26. Nov. 2025, 23:21 UTC

Market Talk

RBNZ Rate Cuts Finally Getting Traction With Consumers -- Market Talk

26. Nov. 2025, 23:02 UTC

Market Talk

Steelmaking Coal Price Signal Knocked by China Import Shift -- Market Talk

26. Nov. 2025, 21:38 UTC

Ergebnisse

These Stocks Moved the Most Today: Alphabet, Nvidia, AMD, Apple, Dell, Robinhood, Deere, HP Inc., Urban Outfitters, and More -- Barrons.com

26. Nov. 2025, 21:25 UTC

Ergebnisse

Li Auto Posts Surprise Loss, Stock Rises. What's Next for Its Diving EV Sales. -- Barrons.com

26. Nov. 2025, 21:17 UTC

Akquisitionen, Fusionen, Übernahmen

Commercial Metals Co Announces Closing of $2B Senior Notes Offering

26. Nov. 2025, 21:16 UTC

Ergebnisse

Deere Beat Earnings Estimates. Why the Stock Is Falling. -- Barrons.com

26. Nov. 2025, 21:09 UTC

Ergebnisse

Roblox Isn't Playing Games. Why the Stock Could -2-

26. Nov. 2025, 21:09 UTC

Ergebnisse

Roblox Isn't Playing Games. Why the Stock Could Jump 50%. -- Barrons.com

26. Nov. 2025, 20:27 UTC

Akquisitionen, Fusionen, Übernahmen

Charter Communications Stock Is a Disaster. The Answer Could Be a 10% Dividend. -- Barrons.com

26. Nov. 2025, 20:25 UTC

Akquisitionen, Fusionen, Übernahmen

Charter Communications Stock Is a Disaster. The Answer Could Be a 10% Dividend. -- Barrons.com

26. Nov. 2025, 20:15 UTC

Ergebnisse

These Stocks Are Moving the Most Today: Alphabet, Nvidia, AMD, Apple, Dell, Robinhood, Deere, HP Inc., Urban Outfitters, and More -- Barrons.com

26. Nov. 2025, 20:08 UTC

Market Talk

Oil Futures Settle Higher in Choppy Trade -- Market Talk

26. Nov. 2025, 20:06 UTC

Market Talk

U.S. Natural Gas Settles Higher Ahead of Holiday -- Market Talk

26. Nov. 2025, 19:30 UTC

Ergebnisse

These Stocks Are Moving the Most Today: Alphabet, Nvidia, AMD, Apple, Dell, Robinhood, Deere, HP Inc., Urban Outfitters, and More -- Barrons.com

26. Nov. 2025, 19:21 UTC

Akquisitionen, Fusionen, Übernahmen

Teck Resources: ISS and Glass Lewis Recommend Teck Hldrs Vote for Anglo American Deal

26. Nov. 2025, 18:43 UTC

Market Talk

U.S. Natural Gas Storage Down for Second Straight Week -- Market Talk

26. Nov. 2025, 18:41 UTC

Market Talk

U.S. Oil Rig Count Falls By 12 to 407 -- Market Talk

26. Nov. 2025, 18:19 UTC

Ergebnisse

Workday Beat Earnings Estimates. The Stock Is Down 10% Anyway. -- Barrons.com

26. Nov. 2025, 17:51 UTC

Ergebnisse

Deere Forecasts Higher Tariff Costs, Less Profit in 2026 -- WSJ

26. Nov. 2025, 17:50 UTC

Ergebnisse

These Stocks Are Moving the Most Today: Alphabet, Nvidia, AMD, Apple, Dell, Robinhood, Deere, HP Inc., Urban Outfitters, and More -- Barrons.com

26. Nov. 2025, 17:20 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Energy & Utilities Roundup: Market Talk

26. Nov. 2025, 17:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

26. Nov. 2025, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

26. Nov. 2025, 17:16 UTC

Ergebnisse

Akquisitionen, Fusionen, Übernahmen

Blue Owl Is Having a Rough Year. Its Co-CEO Says -2-

26. Nov. 2025, 17:16 UTC

Ergebnisse

Akquisitionen, Fusionen, Übernahmen

Blue Owl Is Having a Rough Year. Its Co-CEO Says Investors' Fears Are 'Ungrounded.' -- Barrons.com

Peer-Vergleich

Kursveränderung

Harmony Biosciences Holdings Inc Prognose

Kursziel

By TipRanks

30.16% Vorteil

12-Monats-Prognose

Durchschnitt 46 USD 30.16%

Hoch 62 USD

Tief 32 USD

Basierend auf 10 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Harmony Biosciences Holdings Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

10 ratings

Buy

Halten

Sell

Basierend auf 10 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Harmony Biosciences Holdings Inc – Dist abgegeben haben.

Technischer Score

By Trading Central

29.8 / N/AUnterstützung & Widerstand

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Stimmung

By Acuity

304 / 374 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.